Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate

NCT01209299 · clinicaltrials.gov ↗

COMPLETED

Status

80

Enrollment

NETWORK

Sponsor class

Conditions

Melanoma (Skin)

Interventions

GENETIC: DNA methylation analysis
GENETIC: gene expression analysis
OTHER: laboratory biomarker analysis

Sponsor

ECOG-ACRIN Cancer Research Group

Collaborators

[object Object]